drugset / Trial / NCT02111746
PAIN - Postoperative Analgesia INvestigation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.
Timeline
- Start
- 2013-11-20
- Primary completion
- 2017-05-03
- Completion
- 2017-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 125 mg | Other |
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
| Background | Hydromorphone | Other / unclassified | 0.2 mg | — |
| Background | Hydromorphone | Other / unclassified | 0.4 mg | — |
| Background | Hydromorphone | Other / unclassified | 2 mg | — |
Indications
No indication recorded.